Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Muto

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Clinical and Experimental Nephrology|September 26, 2021
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020Saori Nishio, Ken Tsuchiya, Shinya Nakatani, et al.
Journal of Clinical Medicine|November 11, 2022
Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)Akinari Sekine, Sumi Hidaka, Tomofumi Moriyama, et al.
Clinical and Experimental Nephrology|October 25, 2023
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022Motoko Yanagita, Satoru Muto, Hiroyuki Nishiyama, et al.
Clinical and Experimental Nephrology|December 9, 2023
Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022Motoko Yanagita, Satoru Muto, Hiroyuki Nishiyama, et al.
Clinical and Experimental Nephrology|May 11, 2024
Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP)Shinya Nakatani, Haruna Kawano, Mai Sato, et al.
Clinical and Experimental Nephrology|November 4, 2023
Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney diseaseHiroshi Kataoka, Yosuke Shimada, Tomonori Kimura, et al.
Clinical and Experimental Nephrology|June 27, 2023
Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney diseaseHiroshi Kataoka, Yosuke Shimada, Tomonori Kimura, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Clinical and Experimental Nephrology|September 26, 2021
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020Saori Nishio, Ken Tsuchiya, Shinya Nakatani, et al.
Journal of Clinical Medicine|November 11, 2022
Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)Akinari Sekine, Sumi Hidaka, Tomofumi Moriyama, et al.
Clinical and Experimental Nephrology|October 25, 2023
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022Motoko Yanagita, Satoru Muto, Hiroyuki Nishiyama, et al.
Clinical and Experimental Nephrology|December 9, 2023
Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022Motoko Yanagita, Satoru Muto, Hiroyuki Nishiyama, et al.
Clinical and Experimental Nephrology|May 11, 2024
Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP)Shinya Nakatani, Haruna Kawano, Mai Sato, et al.
Clinical and Experimental Nephrology|November 4, 2023
Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney diseaseHiroshi Kataoka, Yosuke Shimada, Tomonori Kimura, et al.
Clinical and Experimental Nephrology|June 27, 2023
Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney diseaseHiroshi Kataoka, Yosuke Shimada, Tomonori Kimura, et al.
Pageof 13